диссертации / 50
.pdf162.Long FR, Williams RS, Castile RG. Structural airway abnormalities in infants and young children with cystic fibrosis // J Pediatr. - 2004. - 144: 154–161.
163.Mall M, Grubb B, Harkema J, O’Neal W, Boucher R. Increased airway epithelial Na_ absorption produces cystic fibrosis-like lung disease in mice // Nat Med. - 2004. - 10(5): 487-493.
164.Manzke H, Stadlober E, Schellauf HP. Combined body plethysmographic, spirometric and flow volume reference values for male and female children aged 6 to 16 years obtained from "hospital normals \\ Eur J Pediatr. - 2001. - 160: 300–306.
165.Marchant JM, Masel JP, Dickinson FL, Masters IB, Chang AB. Application of chest high-resolution computer tomography in young children with cystic fibrosis // Pediatr Pulmonol. - 2001. - 31: 24–29.
166.Martinez TM, Llapur CJ, Williams TH, et al. High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis // Am J Respir Crit Care Med. - 2005. - 172: 1133–1138.
167.Matsui H, Randell SH, Peretti SW, Davis CW, Boucher RC. Coordinated clearance of periciliary liquid and mucus from airway surfaces // J Clin Invest. - 1998. - 102(6): 1125-1131.
168.Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality // Am J Respir Crit Care Med. - 2002. - 166: 1550–1555.
169.Moss RB, Milla C, Colombo J, Accurso F, Zeitlin PL, Clancy JP, et al. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial // Hum Gene Ther. - 2007. - 18(8): 726-732.
170.Moss RB, Rodman D, Spencer LT, Aitken ML, Zeitlin PL, Waltz D, et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic
131
fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebocontrolled trial // Chest. - 2004. - 125(2): 509-521.
171.Nielsen KG, Pressler T, Klug B, Koch C, Bisgaard H. Serial lung function and responsiveness in cystic fibrosis during early childhood // Am J Respir Crit Care Med. - 2004. - 69: 1209–1216.
172.Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF,Grimwood K, Wainwright C. Early airway infection, inflammation, and lung function in cystic fibrosis // Arch Dis Child. - 2002. - 87: 306–311.
173.Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features // Am J Respir Crit Care Med. - 2004. - 169(4): 459-467.
174.Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments // Eur Respir J. - 2003. - 22: 1026–1041.
175.Pedreira C.C., Robert R.G., Dalton V. et al. Association of body composition and lung function in children with cystic Fibrosis // Pediatr Pulmonol. – 2005.– Vol.39. - №3.– P. 276–280.
176.Quinton PM. The neglected ion: HCO3- // Nat Med. - 2001. - 7(3): 292-293.
177.Ranganathan SC, Stocks J, Dezateux C. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis // Am J Respir Crit Care Med. - 2004. - 169: 928–933.
178.Ratjen F, Bush A. Amiloride, still a viable treatment option for CF patients? // Am J Respir Crit Care Med. - 2008. - 178(12): 1191-1192.
179.Ratjen F, Do¨ring G. Cystic fibrosis // Lancet. - 2003. - 361(9358): 681-689.
132
180.Ratjen F. Diagnosing and managing infection in CF // Paediatr Respir Rev. - 2006. - 7(Suppl 1): S151-S153.
181.Ratjen F. New pulmonary therapies for cystic fibrosis // Curr Opin Pulm Med. - 2007. - 13(6): 541-546.
182.Ratjen F. Restoring airway surface liquid in cystic fibrosis // N Engl J Med. - 2006. - 354(3): 291-293.
183.Ratjen F. What’s new in CF airway inflammation: an update // Paediatr Respir Rev. - 2006. - 7(Suppl 1): S70-S72.
184.Reddy MM, Light MJ, Quinton PM. Activation of the epithelial Na_channel (ENaC) requires CFTR Cl– channel function // Nature. - 1999. - 402(6759): 301-304.
185.Regnis JA, Robinson M, Bailey DL, Cook P, Hooper P, Chan HK, et al. Mucociliary clearance in patients with cystic fibrosis and in normal subjects // Am J Respir Crit Care Med. - 1994. - 150(1): 66-71.
186.Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA // Science. - 1989. - 245(4922): 1066-1073.
187.Riordan JR. CFTR function and prospects for therapy \\ Annu RevBiochem. - 2008. - 77: 701-726.
188.Robinson M, Hemming A, Regnis J, Wong A, Bailey D, Bautovich GJ, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis // Thorax. - 1997. - 52(10): 900903.
189.Robinson W, Waltz DA. FEV(1) as a guide to lung transplant referral in young patients with cystic fibrosis // Pediatr Pulmonol. - 2000. - 30: 198–
202.
133
190.Rommens JM, Iannuzzi MC, Kerem BS, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping // Science. - 1989. - 245(4922): 1059-1065.
191.Rosenfeld M, Gibson RL, McNamara S, et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis
//Pediatr Pulmonol. - 2001. - 32: 356–366.
192.Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis // N Engl J Med. - 2005. - 352(19): 1992-2001.
193.Salvatore F., Scudiero O., Castaldo G. Genotype - phenotype correlation in cystic fibrosis: The role of modifier genes // Am. J. Med. Genet. - 2002. - 111: 88-89.
194.Schibler A, Schneider M, Frey U, Kraemer R. Moment ratio analysis of multiple breath nitrogen washout in infants with lung disease // Eur Respir J. - 2000. - 15:1094–1101.
195.Schwiebert EM, Morales MM, Devidas S, Egan ME, Guggino WB. Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator // Proc Natl Acad Sci USA. - 1998. - 95(5): 2674-89.
196.Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S, et al. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study // BMC Med. - 2007. - 5: 5.
197.Sinaaspel M., Stern M., Littewood J. et al. Nutrition in patient with cystic fibrosis: European Consensus J // Cystic fibrosis. - 2002. - 1: 51-75.
198.Smith J.J., Travis S.M., Greenberg E.P., Welsh M.J, Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
//Cell. - 1996. - 85: 229-236.
134
199.Sommerhof C.P., Nadel G.A., Basbaum J.B., Caughey G.H. Neutrophil elastase and catepsin G stimulate secretion from culture bovine airway glands // J. Clin. Invest. - 1990. - 85: 682-689.
200.Stern RC. The diagnosis of cystic fibrosis // N Engl J Med. - 1997. -
336:487–491.
201.Stiglbauer R, Schurawitzki H, Eichler I, Vergesslich KA, Gotz M. High resolution CT in children with cystic fibrosis. // Acta Radiol. - 1992. -
33:548–553.
202.Tarran R, Button B, Picher M, Paradiso AM, Ribeiro CM, Lazarowski ER, et al. Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections // J Biol Chem. - 2005. - 280(42): 35751-35759.
203.Van Goor F, Straley K, Cao D, Gonzalez J, Hadida S, Hazlewood A, et al. Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules // Am J Physiol Cell Physiol. - 2006. - 290(6): L1117-L1130.
204.Van Muylem A, Baran D. Overall and peripheral inhomogeneity of ventilation in patients with stable cystic fibrosis // Pediatr Pulmonol. - 2000. - 30: 3–9.
205.Verhaeghe C, Delbecque K, de Leval L, et al. Early inflammation in the airways of a cystic fibrosis foetus // J Cyst Fibros. - 2007. - Jan. 11.
206.Wang X, Venable J, LaPointe P, Hutt DM, Koulov AV, Coppinger J, et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis // Cell. - 2006. - 127(4): 803-815.
207.Warner JO, et al. Cystic fibrosis in children, in Respiratory Medicine (second edition), London. - 1995: 1330-40.
135
208.Welch E, Barton E, Zhuo J, Tomizawa Y, Friesen W, Trifillis P, et al. PTC124 targets genetic disorders caused by nonsense mutations // Nature. - 2007. - 447(7140): 87-91.
209.Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations \\ N Engl J Med. - 2003. - 349(15): 14331441.
210.Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients // J Clin Invest. - 2002. - 109(3): 317325.
211.Zeitlin P, Boyle M, Guggino W, Molina L. A phase I trial of intranasal Moli1901 for cystic fibrosis // Chest. - 2004. - 125(1): 143-149.
212.Zhou Z, Treis D, Schubert SC, Harm M, Schatterny J, Hirtz S, et al. Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice // Am J Respir Crit Care Med. - 2008. - 178(12): 1245-1256.
136